Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Rodrigo N. Valle

Associate

Nashville
(615) 742-7808 TEL
(615) 742-0478 FAX

Rodrigo N. Valle

Associate

Nashville
(615) 742-7808 TEL
(615) 742-0478 FAX
Nashville
(615) 742-7808 TEL
(615) 742-0478 FAX

Rod Valle advises clients across a broad range of industries in intellectual property (IP) related matters and technology-based transactions, including license agreements, software and technology service transactions, strategic relationships, and mergers and acquisitions involving technology and IP assets. Rod also works with companies on a variety of trademark and franchise related issues and counsels clients with respect to privacy and data security matters, including data breach responses and customer notifications, investigations of data security incidents, and crafting incident response plans. In addition, Rod has significant experience representing clients with respect to enforcing their intellectual property rights, including handling intellectual property and licensing disputes.

Prior to joining Bass, Berry & Sims, Rod was an associate at Ropes & Gray working out of the New York and Tokyo offices. After law school, he served as an Assistant Attorney General in the Litigation Bureau of the New York State Office of the Attorney General. Prior to law school, Rod worked for the U.S. Environmental Protection Agency as a Life Scientist. Rod is fluent in Spanish and French.

Memberships

American Health Lawyers Association (AHLA)

Arts & Business Council of Greater Nashville - Arts Board Matching Program (Class of 2017)

News

View More

Representative Experience

View More

Publications

View More

Additional Thought Leadership

Publications:

  • "2014 Year-in-Review: Important U.S. Patent Law Developments – A Busy Tech Year" (co-author), Bloomberg BNA Patent, Trademark & Copyright Journal (January 30, 2015)
  • "The Multi-party Infringement Puzzle" (co-author), The Patent Lawyer (November/December 2012)

Presentation:

  • "Protecting Your Secrets: Best Practices in NDA Drafting and Safeguarding Trade Secrets," Presenter, Japan In-House Counsel Network Seminar (June 2014)

Accolades

Oxford International IP Moot Court – First Place

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.